M Gazouli


Affiliation: University of Athens
Country: Greece


  1. Zografos E, Anagnostopoulos A, Papadopoulou A, Legaki E, Zagouri F, Marinos E, et al. Serum Proteomic Signatures of Male Breast Cancer. Cancer Genomics Proteomics. 2019;16:129-137 pubmed publisher
    ..These findings provide valuable insight into the distinct clinicopathological features of MBC and indicate that select serum proteomic markers may help improve MBC management. ..
  2. Koutouratsas T, Kalli T, Karamanolis G, Gazouli M. Contribution of ghrelin to functional gastrointestinal disorders' pathogenesis. World J Gastroenterol. 2019;25:539-551 pubmed publisher
  3. Argyrou A, Legaki E, Koutserimpas C, Gazouli M, Papaconstantinou I, Gkiokas G, et al. Risk factors for gastroesophageal reflux disease and analysis of genetic contributors. World J Clin Cases. 2018;6:176-182 pubmed publisher
    ..Further investigation on the risk genes may elucidate their exact function and role and demonstrate new therapeutic approaches to this increasingly common disease. ..
  4. Gazouli M, Papaconstantinou I, Stamatis K, Vaiopoulou A, Zeglinas C, Vassiliou I, et al. Association study of genetic variants in miRNAs in patients with inflammatory bowel disease: preliminary results. Dig Dis Sci. 2013;58:2324-8 pubmed publisher
    ..Independent studies are needed to validate our findings in larger series and in patients of different ethnic origins. ..
  5. Gazouli M, Anagnostopoulos A, Papadopoulou A, Vaiopoulou A, Papamichael K, Mantzaris G, et al. Serum protein profile of Crohn's disease treated with infliximab. J Crohns Colitis. 2013;7:e461-70 pubmed publisher
  6. request reprint
    Gazouli M, Bouziotis P, Lyberopoulou A, Ikonomopoulos J, Papalois A, Anagnou N, et al. Quantum dots-bevacizumab complexes for in vivo imaging of tumors. In Vivo. 2014;28:1091-5 pubmed
    ..001). In conclusion, we could successfully detect the VEGF-expressing tumors using QDs-bevacizumab nanoprobes in vitro and in vivo, opening new perspectives for VEGF-targeted non-invasive imaging in clinical practice. ..
  7. request reprint
    Gialafos E, Triposkiadis F, Kouranos V, Rapti A, Kosmas I, Manali E, et al. Relationship between tumor necrosis factor-α (TNFA) gene polymorphisms and cardiac sarcoidosis. In Vivo. 2014;28:1125-9 pubmed
    ..We detected an increased presence of genetic polymorphisms in the TNFA gene of patients with cardiac involvement. However, the role and the clinical application of these findings need further exploration. ..
  8. Gazouli M, Lyberopoulou A, Pericleous P, Rizos S, Aravantinos G, Nikiteas N, et al. Development of a quantum-dot-labelled magnetic immunoassay method for circulating colorectal cancer cell detection. World J Gastroenterol. 2012;18:4419-26 pubmed publisher
    ..We have accomplished these results by using magnetic bead isolation and subsequent QD fluorescence detection. The method described here can be easily adjusted for any other protein target of either the CTC or the host. ..
  9. request reprint
    Legaki E, Roubelakis M, Theodoropoulos G, Lazaris A, Kollia A, Karamanolis G, et al. Therapeutic Potential of Secreted Molecules Derived from Human Amniotic Fluid Mesenchymal Stem/Stroma Cells in a Mice Model of Colitis. Stem Cell Rev. 2016;12:604-612 pubmed
    ..Our results demonstrated that CM derived from SS-AF-MSCs cells is able to ameliorate DSS-induced colitis in immunodeficient colitis mouse model, and thus, it has a potential for use in IBD therapy. ..

More Information


  1. request reprint
    Zografos E, Gazouli M, Tsangaris G, Marinos E. The Significance of Proteomic Biomarkers in Male Breast Cancer. Cancer Genomics Proteomics. 2016;13:183-90 pubmed
    ..In this review, an effort is made to summarize the studies and results linked to the implementation of proteomics in the field of MBC detection and diagnosis. ..
  2. Konstantinidou M, Goutas N, Vlachodimitropoulos D, Chaidaroglou A, Stefanou D, Poumpouridou N, et al. TLR-4 and CD14 Genotypes and Soluble CD14: Could They Predispose to Coronary Atherosclerosis?. J Cardiovasc Dev Dis. 2016;3: pubmed publisher
    ..The studied polymorphisms ofTLR-4 showed no association with CAD. Conversely, the functional polymorphism of CD14 has a statistically significant difference in expression between healthy and affected by CAD individuals. ..
  3. request reprint
    Lyberopoulou A, Galanopoulos M, Aravantinos G, Theodoropoulos G, Marinos E, Efstathopoulos E, et al. Identification of Methylation Profiles of Cancer-related Genes in Circulating Tumor Cells Population. Anticancer Res. 2017;37:1105-1112 pubmed
    ..CTCs is a promising diagnostic tool. The combination of genetic mutations and epigenetic aberrations specifically in CTCs, will ameliorate CRC diagnosis in the future. ..
  4. request reprint
    Galanopoulos M, Papanikolaou I, Zografos E, Viazis N, Papatheodoridis G, Karamanolis D, et al. Comparative Study of Mutations in Single Nucleotide Polymorphism Loci of KRAS and BRAF Genes in Patients Who Underwent Screening Colonoscopy, With and Without Premalignant Intestinal Polyps. Anticancer Res. 2017;37:651-657 pubmed
  5. Gazouli M. Circulating microRNAs in Inflammatory Bowel Diseases. Exp Suppl. 2015;106:197-214 pubmed publisher
    ..In this chapter, the role of microRNAs in IBD and the most promising circulating microRNAs will be discussed that could be used as noninvasive biomarkers for IBD diagnosis. ..
  6. Karageorgopoulou S, Kostakis I, Gazouli M, Markaki S, Papadimitriou M, Bournakis E, et al. Prognostic and predictive factors in patients with metastatic or recurrent cervical cancer treated with platinum-based chemotherapy. BMC Cancer. 2017;17:451 pubmed publisher
    ..ERCC1 N118 N and MDR1 G2677 T polymorphism also proved of prognostic significance for disease progression, while overexpression of III β-tubulin was positively correlated with chemotherapy resistance. ..
  7. request reprint
    Gazouli M, Zavos G, Papaconstantinou I, Lukas J, Zografidis A, Boletis J, et al. The interleukin-6-174 promoter polymorphism is associated with a risk of development of Kaposi's sarcoma in renal transplant recipients. Anticancer Res. 2004;24:1311-4 pubmed
    ..In addition to the HHV-8 infection, the interleukin-6 promoter polymorphism G-174C is associated with a risk of development of KS in renal transplant recipients. ..
  8. Moschos M, Pantazis P, Gatzioufas Z, Panos G, Gazouli M, Nitoda E, et al. "Association between platelet activating factor acetylhydrolase and diabetic retinopathy: Does inflammation affect the retinal status?". Prostaglandins Other Lipid Mediat. 2016;122:69-72 pubmed publisher
    ..114 μmol/min/ml, post-hoc Bonferroni comparison test: p<0.0001) and to NPDR group (0.147 μmol/min/ml, post-hoc Bonferroni comparison test: p=0.012). The activity of PAF-AH in the plasma increases in parallel with DR severity. ..
  9. Tsigaridas A, Anagnostopoulos A, Papadopoulou A, Ioakeim S, Vaiopoulou A, Papanikolaou I, et al. Identification of serum proteome signature of irritable bowel syndrome: Potential utility of the tool for early diagnosis and patient's stratification. J Proteomics. 2018;188:167-172 pubmed publisher
    ..Our results show that there is a different serum proteome signature in IBS compared to healthy individuals, as well as in IBS subgroups that could be used in the future for patient's stratification and as a diagnostic tool. ..
  10. Papaconstantinou I, Kapizioni C, Legaki E, Xourgia E, Karamanolis G, Gklavas A, et al. Association of miR-146 rs2910164, miR-196a rs11614913, miR-221 rs113054794 and miR-224 rs188519172 polymorphisms with anti-TNF treatment response in a Greek population with Crohn's disease. World J Gastrointest Pharmacol Ther. 2017;8:193-200 pubmed publisher
    ..No correlation is detected between studied polymorphisms and patients' response to anti-TNF treatment. Polymorphism rs113054794 is not detected in our population. ..
  11. Gazouli M, Pachoula I, Panayotou I, Mantzaris G, Chrousos G, Anagnou N, et al. NOD2/CARD15, ATG16L1 and IL23R gene polymorphisms and childhood-onset of Crohn's disease. World J Gastroenterol. 2010;16:1753-8 pubmed
    ..The ATG16L1 and IL23R variants are associated with susceptibility to CD, but not early-onset disease. ..
  12. Gazouli M, Atsaves V, Mantzaris G, Economou M, Nasioulas G, Evangelou K, et al. Role of functional polymorphisms of NRAMP1 gene for the development of Crohn's disease. Inflamm Bowel Dis. 2008;14:1323-30 pubmed publisher
    ..Collectively, our data indicate that genetic polymorphisms of NRAMP1 might be associated with susceptibility to CD. ..
  13. request reprint
    Gazouli M, Koundourakis A, Ikonomopoulos J, Gialafos E, Rapti A, Gorgoulis V, et al. CARD15/NOD2, CD14, and toll-like receptor 4 gene polymorphisms in Greek patients with sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis. 2006;23:23-9 pubmed
    ..Our results suggest that the G908R mutation of the CARD15/NOD2 gene, as well as the T allele and TT genotype of the CD14 promoter are associated with increased susceptibility for developing sarcoidosis. ..